Cargando…

The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study

Background: Individuals with 22q11.2 deletion syndrome (22q11DS) are at increased risk of developing psychosis and cognitive impairments, which may be related to dopaminergic and glutamatergic abnormalities. Therefore, in this exploratory study, we examined the association between dopaminergic and g...

Descripción completa

Detalles Bibliográficos
Autores principales: van Hooijdonk, Carmen F. M., Tse, Desmond H. Y., Roosenschoon, Julia, Ceccarini, Jenny, Booij, Jan, van Amelsvoort, Therese A. M. J., Vingerhoets, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498700/
https://www.ncbi.nlm.nih.gov/pubmed/36140839
http://dx.doi.org/10.3390/genes13091672
_version_ 1784794825129721856
author van Hooijdonk, Carmen F. M.
Tse, Desmond H. Y.
Roosenschoon, Julia
Ceccarini, Jenny
Booij, Jan
van Amelsvoort, Therese A. M. J.
Vingerhoets, Claudia
author_facet van Hooijdonk, Carmen F. M.
Tse, Desmond H. Y.
Roosenschoon, Julia
Ceccarini, Jenny
Booij, Jan
van Amelsvoort, Therese A. M. J.
Vingerhoets, Claudia
author_sort van Hooijdonk, Carmen F. M.
collection PubMed
description Background: Individuals with 22q11.2 deletion syndrome (22q11DS) are at increased risk of developing psychosis and cognitive impairments, which may be related to dopaminergic and glutamatergic abnormalities. Therefore, in this exploratory study, we examined the association between dopaminergic and glutamatergic functioning in 22q11DS. Additionally, the associations between glutamatergic functioning and brain volumes in 22q11DS and healthy controls (HC), as well as those between dopaminergic and cognitive functioning in 22q11DS, were also examined. Methods: In this cross-sectional, multimodal imaging study, glutamate, glutamine, and their combined concentration (Glx) were assessed in the anterior cingulate cortex (ACC) and striatum in 17 22q11DS patients and 20 HC using 7T proton magnetic resonance spectroscopy. Ten 22q11DS patients also underwent (18)F-fallypride positron emission tomography to measure dopamine D(2/3) receptor (D(2/3)R) availability in the ACC and striatum. Cognitive performance was assessed with the Cambridge Neuropsychological Test Automated Battery. Results: No significant associations were found between ACC or striatal (1) glutamate, glutamine, or Glx concentrations and (2) D(2/3)R availability. In HC but not in 22q11DS patients, we found a significant relationship between ACC volume and ACC glutamate, glutamine, and Glx concentration. In addition, some aspects of cognitive functioning were significantly associated with D(2/3)R availability in 22q11DS. However, none of the associations remained significant after Bonferroni correction. Conclusions: Although our results did not reach statistical significance, our findings suggest an association between glutamatergic functioning and brain volume in HC but not in 22q11DS. Additionally, D(2/3)R availability seems to be related to cognitive functioning in 22q11DS. Studies in larger samples are needed to further elucidate our findings.
format Online
Article
Text
id pubmed-9498700
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94987002022-09-23 The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study van Hooijdonk, Carmen F. M. Tse, Desmond H. Y. Roosenschoon, Julia Ceccarini, Jenny Booij, Jan van Amelsvoort, Therese A. M. J. Vingerhoets, Claudia Genes (Basel) Article Background: Individuals with 22q11.2 deletion syndrome (22q11DS) are at increased risk of developing psychosis and cognitive impairments, which may be related to dopaminergic and glutamatergic abnormalities. Therefore, in this exploratory study, we examined the association between dopaminergic and glutamatergic functioning in 22q11DS. Additionally, the associations between glutamatergic functioning and brain volumes in 22q11DS and healthy controls (HC), as well as those between dopaminergic and cognitive functioning in 22q11DS, were also examined. Methods: In this cross-sectional, multimodal imaging study, glutamate, glutamine, and their combined concentration (Glx) were assessed in the anterior cingulate cortex (ACC) and striatum in 17 22q11DS patients and 20 HC using 7T proton magnetic resonance spectroscopy. Ten 22q11DS patients also underwent (18)F-fallypride positron emission tomography to measure dopamine D(2/3) receptor (D(2/3)R) availability in the ACC and striatum. Cognitive performance was assessed with the Cambridge Neuropsychological Test Automated Battery. Results: No significant associations were found between ACC or striatal (1) glutamate, glutamine, or Glx concentrations and (2) D(2/3)R availability. In HC but not in 22q11DS patients, we found a significant relationship between ACC volume and ACC glutamate, glutamine, and Glx concentration. In addition, some aspects of cognitive functioning were significantly associated with D(2/3)R availability in 22q11DS. However, none of the associations remained significant after Bonferroni correction. Conclusions: Although our results did not reach statistical significance, our findings suggest an association between glutamatergic functioning and brain volume in HC but not in 22q11DS. Additionally, D(2/3)R availability seems to be related to cognitive functioning in 22q11DS. Studies in larger samples are needed to further elucidate our findings. MDPI 2022-09-19 /pmc/articles/PMC9498700/ /pubmed/36140839 http://dx.doi.org/10.3390/genes13091672 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
van Hooijdonk, Carmen F. M.
Tse, Desmond H. Y.
Roosenschoon, Julia
Ceccarini, Jenny
Booij, Jan
van Amelsvoort, Therese A. M. J.
Vingerhoets, Claudia
The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study
title The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study
title_full The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study
title_fullStr The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study
title_full_unstemmed The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study
title_short The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study
title_sort relationships between dopaminergic, glutamatergic, and cognitive functioning in 22q11.2 deletion syndrome: a cross-sectional, multimodal (1)h-mrs and (18)f-fallypride pet study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498700/
https://www.ncbi.nlm.nih.gov/pubmed/36140839
http://dx.doi.org/10.3390/genes13091672
work_keys_str_mv AT vanhooijdonkcarmenfm therelationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy
AT tsedesmondhy therelationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy
AT roosenschoonjulia therelationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy
AT ceccarinijenny therelationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy
AT booijjan therelationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy
AT vanamelsvoortthereseamj therelationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy
AT vingerhoetsclaudia therelationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy
AT vanhooijdonkcarmenfm relationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy
AT tsedesmondhy relationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy
AT roosenschoonjulia relationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy
AT ceccarinijenny relationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy
AT booijjan relationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy
AT vanamelsvoortthereseamj relationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy
AT vingerhoetsclaudia relationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy